I’m working on several exciting projects. Some of these are late-stage projects focused on publishing our results. One manuscript, MEK inhibitor in rhabdomyosarcoma, has been
I’m working on several exciting projects. Some of these are late-stage projects focused on publishing our results. One manuscript, MEK inhibitor in rhabdomyosarcoma, has been
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2024 – Children’s Cancer Therapy Development Institute